Lynparza in combination with Abiraterone and Prednisone approved in the EU as treatment for metastatic castration-resistant prostate cancer
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
The scheme is subject to statutory and regulatory approvals as may be necessary.
The advanced laboratory spread over 2,200 Square feet has multiple laboratory divisions including Hematology, Biochemistry, Clinical pathology, Serology and Microbiology
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
UHI is envisioned as a foundational layer of the Ayushman Bharat Digital Mission and aims to enable interoperability in health services in India through open protocols
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
Subscribe To Our Newsletter & Stay Updated